EDGAR·FLOW

Cencora, Inc. — Form 8-K

Filed October 21, 2026 · analyzed by the 8-K Agent
8-K ▲ Likely positive significance 52/100
What the filing says
Cencora signed a definitive agreement to acquire American Oncology Network (AON), a physician-led oncology network of 350+ providers across 21 states, for $2.4B enterprise value ($2.3B at closing plus up to $100M in CVRs). Cencora currently owns ~4% of AON; the deal values AON at $2.4B total, with Cencora expecting to pay ~$1.7B at closing to reach 75% ownership (assuming 25% equity rollover by certain AON stockholders). The acquisition is expected to be accretive to adjusted diluted EPS in year two post-closing.
Why this rating

~4.5% of market cap in cash outlay; meaningful but not transformational; strengthens MSO platform; moderate integration execution risk.

View original filing on SEC.gov ↗ COR · stock on Yahoo Finance ↗

See more from October 21, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.